BACKGROUND: The value of creatine phosphokinase (CPK) monitoring during isotretinoin therapy is still a matter of debate because of the rarity of muscular and kidney damage in this setting. The aim of the study was to investigate the incidence of CPK elevation during a low starting dose isotretinoin regimen and to discuss the clinical approach to patients with increased CPK. METHODS: We reviewed the records of the acne patients from 2015 to 2018 at the University of Ferrara and at the University of Modena and Reggio Emilia. Routine clinical and laboratory follow-up was analyzed. RESULTS: The records of 328 patients were included in the study. Abnormal CPK levels were observed in 5.5% of cases. Revised Leeds acne scores and visual assessment scale (VAS) measurements decreased significantly after isotretinoin therapy. DISCUSSION: The adoption of the low starting dose isotretinoin regimen is associated with low incidence of CPK elevation. The finding of CPK over the conventional value of 5 times above the limit was rarely observed and was never associated with kidney damage. Therefore, it should be interpreted as a relatively benign phenomenon that does not require the interruption of isotretinoin therapy and that should be managed mainly through the reassurance of the patient.
BACKGROUND: The value of creatine phosphokinase (CPK) monitoring during isotretinoin therapy is still a matter of debate because of the rarity of muscular and kidney damage in this setting. The aim of the study was to investigate the incidence of CPK elevation during a low starting dose isotretinoin regimen and to discuss the clinical approach to patients with increased CPK. METHODS: We reviewed the records of the acne patients from 2015 to 2018 at the University of Ferrara and at the University of Modena and Reggio Emilia. Routine clinical and laboratory follow-up was analyzed. RESULTS: The records of 328 patients were included in the study. Abnormal CPK levels were observed in 5.5% of cases. Revised Leeds acne scores and visual assessment scale (VAS) measurements decreased significantly after isotretinoin therapy. DISCUSSION: The adoption of the low starting dose isotretinoin regimen is associated with low incidence of CPK elevation. The finding of CPK over the conventional value of 5 times above the limit was rarely observed and was never associated with kidney damage. Therefore, it should be interpreted as a relatively benign phenomenon that does not require the interruption of isotretinoin therapy and that should be managed mainly through the reassurance of the patient.
Authors: A Nast; B Dréno; V Bettoli; Z Bukvic Mokos; K Degitz; C Dressler; A Y Finlay; M Haedersdal; J Lambert; A Layton; H B Lomholt; J L López-Estebaranz; F Ochsendorf; C Oprica; S Rosumeck; T Simonart; R N Werner; H Gollnick Journal: J Eur Acad Dermatol Venereol Date: 2016-08 Impact factor: 6.166
Authors: M Manfredini; M Greco; F Farnetani; G Mazzaglia; S Ciardo; V Bettoli; A Virgili; G Pellacani Journal: Skin Res Technol Date: 2016-06-08 Impact factor: 2.365
Authors: Andrea L Zaenglein; Arun L Pathy; Bethanee J Schlosser; Ali Alikhan; Hilary E Baldwin; Diane S Berson; Whitney P Bowe; Emmy M Graber; Julie C Harper; Sewon Kang; Jonette E Keri; James J Leyden; Rachel V Reynolds; Nanette B Silverberg; Linda F Stein Gold; Megha M Tollefson; Jonathan S Weiss; Nancy C Dolan; Andrew A Sagan; Mackenzie Stern; Kevin M Boyer; Reva Bhushan Journal: J Am Acad Dermatol Date: 2016-02-17 Impact factor: 11.527
Authors: Kimbra Kenney; Mark E Landau; Rodney S Gonzalez; Julie Hundertmark; Karen O'Brien; William W Campbell Journal: Muscle Nerve Date: 2012-03 Impact factor: 3.217
Authors: Priscilla M Clarkson; Amy K Kearns; Pierre Rouzier; Richard Rubin; Paul D Thompson Journal: Med Sci Sports Exerc Date: 2006-04 Impact factor: 5.411
Authors: Ester Del Duca; Marco Manfredini; Nerella Petrini; Francesca Farnetani; Johanna Chester; Luigi Bennardo; Giusy Schipani; Federica Tamburi; Mario Sannino; Giovanni Cannarozzo; Giovanni Pellacani; Steven P Nisticò Journal: Ital J Dermatol Venerol Date: 2019-09-12
Authors: Folasade F Fayiga; Sophia C Reyes-Hadsall; Ludonir C Sebastiany; Sergey Arutyunyan; Alan Wong; Ana M Duarte Journal: Skin Appendage Disord Date: 2021-07-28